Skip to content
Research Article Open access CC BY 4.0

Post-Market Surveillance of Medical Devices Using AI

Tushar Khinvasara, Nikolaos Tzenios, Abhishek Shankar

Journal of Complementary and Alternative Medical Research · pp. 108–122 · Published 29 Jun 2024

10.9734/jocamr/2024/v25i7552

Abstract

Artificial intelligence (AI) has emerged as a transformative tool in post-market surveillance (PMS) for monitoring the safety and performance of medical products. This article explores the role of AI in optimizing PMS practices, focusing on its applications in signal detection, risk assessment, and regulatory compliance. By harnessing machine learning algorithms and big data analytics, AI facilitates the automated analysis of real-world evidence, including patient outcomes data, adverse event reports, and electronic health records. Through pattern recognition and anomaly detection, AI algorithms enable the early identification of potential safety issues and facilitate timely interventions to mitigate risks. Moreover, AI-driven PMS systems enhance regulatory oversight by providing regulators with comprehensive and actionable insights into product safety profiles and emerging trends. However, concerns regarding data privacy, algorithm bias, and interpretability underscore the need for transparent and ethically responsible AI deployment in PMS frameworks.

PMS (Post-Market Surveillance) artificial intelligence medical devices healthcare

Cited by 27

Regulatory Complexities in MDSAP: Challenges and Pathways for Implantable Medical Device Approval

S. Kumbhar, Shreya Khadtare, Snehal Zoman · Biomedical Materials & Devices · 2025

Global harmonization in advanced therapeutics: balancing innovation, safety, and access.

Ankit Dahiya, Kartikey Singh, Anunav Ashish · Personalized Medicine · 2025

Artificial intelligence in stroke rehabilitation: From acute care to long-term recovery.

S. Kopalli, Madhu Shukla, B. Jayaprakash · Neuroscience · 2025

Artificial Intelligence and Machine Learning Implemented Drug Delivery Systems: A Paradigm Shift in the Pharmaceutical Industry

Goutam Kumar Jena, Ch Niranjan Patra, Sruti Jammula · Journal of Bio-X Research · 2024

Artificial intelligence-enabled nanomedicine: enhancing drug design and predictive modeling in pharmaceutics

Omnia M Sarhan, Mostafa I Gebril, Doaa Elsegaie · Journal of Pharmacy and Pharmacology · 2025

Оценка надежности и эффективности систем искусственного интеллекта в лучевой диагностике на этапе эксплуатации

В.В. Зинченко, А.В. Владзимирский, К.М. Арзамасов · МОДЕЛИРОВАНИЕ, ОПТИМИЗАЦИЯ И ИНФОРМАЦИОННЫЕ ТЕХНОЛОГИИ · 2025

Future Directions and Opportunities

Peeyush Phogat, Shreya Sharma, Soumya Rai · Engineering Materials · 2025

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

27

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.